List Title | APhA DrugInfoLine

OTC Medicines Corner

SORT BY: Most Recent Most Viewed

November 27, 2018

Factors that may predict sustained efficacy after a short course of OTC PPIs

READ

PREVIEW
Heartburn resolution within 7 days following completion of a 2-week course of OTC proton pump inhibitor (PPI) therapy (i.e., esomeprazole) was more common in patients who had less baseline...
November 13, 2018

Folic acid and multivitamin use may decrease autism risk

READ

PREVIEW
Maternal exposure to folic acid and/or multivitamins (MVI) before and during pregnancy was associated with a lower risk of autism spectrum disorder in the child compared with no exposure,...
November 6, 2018

A bleak picture of aspirin for primary prevention in older adults

READ

PREVIEW
Three publications in the New England Journal of Medicine from the ASPREE trial showed that daily use of low-dose aspirin in healthy, community-dwelling older people without documented...
September 4, 2018

One-dose-fits-all approach to aspirin therapy for primary prevention is not ideal

READ

PREVIEW
The benefits of aspirin therapy appear to be dose dependent, with patients of higher body weight (≥70 kg) requiring higher doses to prevent cardiovascular (CV) events, and similar results observed...
August 14, 2018

Nearly one-third of children use dietary supplements

READ

PREVIEW
An analysis of data from the National Health and Nutrition Examination Surveys (NHANES) from 2003 to 2014 published in JAMA Pediatrics found that approximately 33% of children and young...

Pages

Medication Monitor

RSS Follow Medication Monitor on Twitter Follow APhA Druginfoline on Twitter

2215 Constitution Avenue NW, Washington, DC 20037 Telephone 202-628-4410 Fax 202-783-2351

© 2013 American Pharmacists Association All Rights Reserved.

About the American
Pharmacists Association

The American Pharmacists Association (APhA) is the organization whose members are recognized in society as essential in all patient care settings for optimal medication use that improves health, wellness and quality of life. Through information, education and advocacy, APhA empowers its members to improve medication use and advance patient care.

About APhA DrugInfoLine

APhA DrugInfoLine (ISSN 2162-3015) is a weekly publication of, and is owned and copyrighted by the American Pharmacists Association, the national professional society of pharmacists. Materials in APhA DrugInfoLine do not neccessarily represent the policy, recommendations, or endorsement of APhA. The publisher, authors, editors, reviewers, and contributors have taken care to ensure that the information contained in APhA DrugInfoLine is accurate and current; however, they shall have no ability to any person or entity with regard to claims, losses, or damage caused or alleged to be caused, directly or indirectly by use of any information contained in the publication. All decisions about drug therapy must be based on independent judgement of the clinician.